Schocket scleral depressor
Diagnostic TestUse of this instrument to examine one eye
NCT Number: NCT06683209
The scleral depression exam is an important routine technique for evaluating the retinal periphery for various reasons. During this examination, an instrument is used to bring the anterior part of the retina into the physician's field of view. The downside of this technique is the discomfort it may cause the patient. Different instruments can be used to depress the sclera.
The objective of this research is to compare three commonly used scleral depressors based on their performance for the ophthalmologist and the discomfort they subjectively induce in patients.
Patients will be randomly allocated to one of three examination groups:
Group A: One eye examined with the Schocket scleral depressor, the other eye with the Josephberg-Besser scleral depressor.
Group B: One eye examined with the Schocket scleral depressor, the other eye with the cotton-tip applicator.
Group C: One eye examined with the cotton-tip applicator, the other eye with the Josephberg-Besser scleral depressor.
Trial opening soon.
Get Notified18 year–100 year
All sexes
Interventional
Not applicable
Alberta Retina Consultant, Edmonton, Alberta, Canada
Background The scleral depression exam is an important technique for evaluating the retinal periphery during indirect ophthalmoscopy. Despite the advent of ultra-widefield fundus imaging, scleral depression provides greater sensitivity in detecting peripheral lesions, such as retinal tears. It was found that 11% of retinal tears were missed when employing non-contact slit-lamp examination, compared to indirect ophthalmoscopy with scleral depression, and a scleral depression exam is widely considered the gold standard for ruling out retinal tears. While there is no international consensus, the preferred practice guideline (American Academy of Ophthalmology) for assessing peripheral vitreoretinal pathology is by indirect ophthalmoscopy combined with scleral depression.
There are a variety of ophthalmic instruments that an eye care professional may use to perform scleral depression. While the exam is uncomfortable, there is a lack of studies comparing patient comfort with different instruments. In this prospective study, we will compare subjective patient pain scores using the Schocket scleral depressor, the Josephberg-Besser scleral depressor, and the cotton-tipped applicator.
Purpose To assess patient pain scores for three common scleral indentation devices and determine which is most comfortable for patients.
Objective / Hypothesis Based on clinical experience, the hypothesis is that the Josephberg-Besser scleral depressor causes less discomfort due to its design.
Study Design Prospective comparative analysis.
Methods Patients will be recruited at two tertiary referral centers (Alberta Retinal Consultants, Edmonton, Alberta, and Sunnybrook Hospital, Department of Ophthalmology & Vision Sciences, Toronto, Ontario) upon consent to participate. Subject identification will be based on the referral indication (symptomatic posterior vitreous detachment with or without vitreoretinal pathology) and the absence of exclusion criteria (i.e., patients who require a scleral indentation examination based on the presenting symptoms). Patients will then be randomly allocated to one of three groups. Additionally, within each group, the symptomatic eye will be randomized.
Patients will be dilated with 1% tropicamide and 2.5% phenylephrine for 30 minutes. Instillation of local anesthetic drops will be used to eliminate any confounding exposure-related keratalgia or ocular surface irritation. Indirect ophthalmoscopic evaluation of the retinal periphery will be undertaken using the provider's lens of choice (20 or 28-diopter lens). The lens and illumination settings will be kept the same for each eye. A similar amount of time and effort will be spent on both eyes.
Following the examination, both patients and physicians will be asked to provide responses to the survey questions provided (surveys enclosed).
Statistical analysis will be performed using R statistical software. Randomization to treatment will be created using Python programming software.
Exclusions:
Monocular status. Media opacity that precludes view of the peripheral retina. Inadequate examination (cooperation with examination, inability to achieve all directions of gaze).
Underlying oculodynia (recent surgery, intraocular inflammation, abnormal intraocular pressure, ocular dysesthesia syndromes (ocular, adnexal, or orbital)).
History of pain-sensitizing conditions or current analgesic use. Previous scleral indentation examination poorly tolerated.
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Use of this instrument to examine one eye
Use of this instrument to examine one eye
Use of this instrument to examine one eye
Time frame: Once, directly after completing the scleral depressed examination, on the same day of inclusion in the study.
Patient rate their pain with the Wong-Baker Faces scale for each eye, from 0 to 10, 0 being the absence of pain and 10 being the worst imaginable pain.
Time frame: Once, directly after completing the scleral depressed examination, on the same day of inclusion in the study.
Physician rate their proficiency with the scleral depressor used
o No difficulty o Some difficulty o Significant difficulty
Time frame: Once, directly after completing the scleral depressed examination, on the same day of inclusion in the study.
Physician rate their proficiency with the scleral depressor used
o No difficulty o Some difficulty o Significant difficulty
Time frame: Once, directly after completing the scleral depressed examination, on the same day of inclusion in the study.
Physician rate their proficiency with the scleral depressor used. Indentation area of the medium light setting of the ophthalmoscope while using a 28D lens. Small is less than 1/3, medium is between 1/3 and 2/3, large is more than 2/3.
Time frame: Once, directly after completing the scleral depressed examination, on the same day of inclusion in the study.
Physician rate their proficiency with the scleral depressor used
o No difficulty o Some difficulty o Significant difficulty
Time frame: Time mesure will be during the examination of each eye
The scleral depressed examination will be timed to ensure a similar duration between each eye
Time frame: The physician will note his findings right after his examination, while completing his examination survey
The physician will annotate his findings based on the number and the type of retinal pathology (tear, hole, lattice, other) found.
Time frame: Before recruiting patients
Participating physician must state their routine instrument for scleral depression.
o Schocket o Josephberg-Besser o Cotton tip applicator
Time frame: Before recruiting patients
Participating physician must state their routinely used lens for scleral depression 20 diopters or 28 diopters
Contact information is provided by the study sponsor or research team.
Mathieu Carrière, MD, FRCSC
CONTACT
Parampal Grewal
CONTACT
University of Alberta
Other
Comparison of Scleral Indentation Instruments and Impact on Patient Comfort
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07712874
Neurologic Manifestations, Pain
Bethesda, Maryland, United States
View Trial DetailsNCT07738965
Chronic Non Specific Low Back Pain, Core Strength
Lahore, Punjab Province, Pakistan
View Trial DetailsNCT07739771
Behavior, Chemotherapeutic Toxicity
Madrid, Spain
View Trial DetailsNCT07737392
Behavior, Health Behavior
Houston, Texas, United States
View Trial Details